© 2021 RSM US LLP. All rights reserved.
Using ERP to accelerate growth in the life sciences market
Whether a pharmaceutical, biotech, medical device or clinical services provider, the demands of life sciences companies change rapidly. This requires an agile ERP system that can scale with your business. The correct ERP can help manage common challenges, provide real-time visibility into expenses and revenue, and provide tools for consolidation and reporting as you grow.
How does NetSuite stack up to the competition?
The ERP software market encompasses many vendors, offering several diverse cloud ERP applications. Below are some of the products that are commonly compared against NetSuite ERP:
Download NetSuite Life Sciences Buyer's Guide
In this guide, you'll find information on NetSuite pricing, comprehensive product information, and instructions on how to qualify and purchase.
Case study: Amring Pharmaceuticals
Amring was looking for a system that was scalable with a minimal information technology (IT) footprint, potentially cloud-based and with a quick implementation timeline.
Key implementation outcomes:
- More comprehensive and real-time financial information for management, including custom dashboards and reporting
- Increased automation to streamline key AP, purchasing and GL functions and reduced manual efforts in Excel
- Enhanced backup information for audit in NetSuite
- Enabled employees to focus on core finance functions, while gaining efficiency in transactional processes
Life Sciences Outlook and Demonstration
In this pre-recorded session, hear from RSM advisors on a brief industry outlook along with a demonstration of how life sciences firms are streamlining processes by leveraging Oracle NetSuite to create better efficiencies pre and post commercialization.
The demonstration will cover functionality including finance and controls, dashboards/reporting, procurement, commercialization, and inventory.
At RSM, we make a commitment to understand you, your passion for life sciences and the importance of your scientific work. We know your research and science is just as important as the business side of your organization. We’re dedicated to helping you with your business challenges and opportunities to leverage technology to support commercialization and initial public offerings.
Our RSM team has developed unique implementation accelerators and industry specific IP to advance implementation timelines to support rapid growth, especially as merger and acquisition (M&A) activity, IPOs, and commercialization come into the picture. This includes specific IP for clinical trials along with direct integration accelerators for leading purchasing platforms, like Prendio.